Utilizing AI & Computational Tools for Heightened Multi-Omics Analysis to Inform Disease Mechanisms & Novel Therapeutic Development

• Blending academic and industry perspectives on the opportunities to elevate AI-driven drug discovery applications through the power of quantum computing
• Applying state-of-the-art computational modeling to investigate multi-omics human data, leveraging disease mechanism insights to develop novel cardiovascular therapies
• Laying out experimental validation with in vivo results of cardiovascular candidate developed from computational multi-omics analysis

Speakers:

Namshik Han

Chief Technology Officer

CardiaTec